Business Context and Reporting Period
This Form 6-K filing by Shinhan Financial Group Co., Ltd. covers the month of December 2025, specifically reporting a board decision made on December 4, 2025. The filing addresses a strategic capital management action rather than periodic financial results.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, or liquidity ratios. The primary financial data point disclosed is the authorization for a new capital issuance:
- Instrument: Bail-in contingent capital securities (hybrid securities).
- Authorized Amount: KRW 270 billion (with a board-approved limit of up to KRW 400 billion depending on demand).
- Structure: Domestic, unregistered, unsecured, uncollateralized, and perpetual.
- Call Provision: Redeemable by the issuer at every interest payment date (3 months) after 5 years, but no later than 10 years from issuance.
Material Changes
The material change reported is the Board of Directors' decision to issue bail-in contingent capital securities to maintain capital requirements under Basel III regulations. This represents a shift in the company's capital structure to enhance regulatory compliance and financial resilience.
Guidance, Outlook, and Risks
Management Commentary: The issuance is explicitly intended to maintain capital requirements under Basel III. Specific interest rates and final issuance details are delegated to the Chief Executive Officer.
Risks and Contingencies: The securities contain a "Point of Non-Viability" trigger. Under Article 2 of the Act on the Structural Improvement of the Financial Industry, the total amount of these securities (including accrued interests or dividends) will be written off without prior consent if the issuing company is designated as an insolvent financial institution.
Investor Verification Checklist
- Confirm the final issuance amount, as it may vary between KRW 270 billion and KRW 400 billion based on demand forecasts.
- Verify the specific interest rate and dividend terms once delegated by the CEO.
- Review the company's current capital adequacy ratios to understand the immediate impact of this Basel III compliance measure.
- Assess the implications of the "Point of Non-Viability" write-off clause on the risk profile of the company's hybrid capital.